Overcoming cancer immunotherapy barriers via nanomaterial-mediated pyroptosis

While cancer immunotherapy has achieved groundbreaking clinical success, its efficacy is frequently compromised by insufficient T-cell activation, the immunosuppressive tumor microenvironment (TME), and off-target toxicity.